These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3568698)

  • 1. Conditional power calculations as an aid in the decision whether to continue a clinical trial.
    Andersen PK
    Control Clin Trials; 1987 Mar; 8(1):67-74. PubMed ID: 3568698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional power for arbitrary survival curves to decide whether to extend a clinical trial.
    Henderson WG; Fisher SG; Weber L; Hammermeister KE; Sethi G
    Control Clin Trials; 1991 Apr; 12(2):304-13. PubMed ID: 1645642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data monitoring in clinical trials: the case for stochastic curtailment.
    Davis BR; Hardy RJ
    J Clin Epidemiol; 1994 Sep; 47(9):1033-42. PubMed ID: 7730906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional power as an aid in making interim decisions in observational studies.
    Walker AM
    Eur J Epidemiol; 2018 Sep; 33(9):777-784. PubMed ID: 29808341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stochastically curtailed phase II clinical trials.
    Ayanlowo AO; Redden DT
    Stat Med; 2007 Mar; 26(7):1462-72. PubMed ID: 16900560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flexible stochastic curtailing procedure for the log-rank test.
    Bautista OM; Bain RP; Lachin JM
    Control Clin Trials; 2000 Oct; 21(5):428-39. PubMed ID: 11018561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential or fixed sample trial design? A case study by stochastic simulation.
    Skovlund E; Walløe L
    J Clin Epidemiol; 1991; 44(3):265-72. PubMed ID: 1999686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and prediction of subject accrual and event times in clinical trials: a systematic review.
    Zhang X; Long Q
    Clin Trials; 2012 Dec; 9(6):681-8. PubMed ID: 22674642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybridization of conditional and predictive power for futility assessment in sequential clinical trials with time-to-event outcomes: a resampling approach.
    Yi J; Fang L; Su Z
    Contemp Clin Trials; 2012 Jan; 33(1):138-42. PubMed ID: 21983624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional power calculations for clinical trials with historical controls.
    Korn EL; Freidlin B
    Stat Med; 2006 Sep; 25(17):2922-31. PubMed ID: 16479548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CP function: an alpha spending function based on conditional power.
    Jiang Z; Wang L; Li C; Xia J; Wang W
    Stat Med; 2014 Nov; 33(26):4501-14. PubMed ID: 25100033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical considerations in terminating randomization in the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Hardy RJ; Davis BR; Palmer EA; Tung B
    Control Clin Trials; 1991 Apr; 12(2):293-303. PubMed ID: 1645641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power and sample size calculations for stochastic cost-effectiveness analysis.
    Briggs AH; Gray AM
    Med Decis Making; 1998; 18(2 Suppl):S81-92. PubMed ID: 9566469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and piloting of a decision aid for women considering participation in the Sentinel Node Biopsy versus Axillary Clearance 2 breast cancer trial.
    Juraskova I; Butow P; Fisher A; Bonner C; Anderson C; Bu S; Scarlet J; Stockler MR; Wetzig N; Ung O; Campbell I
    Clin Trials; 2015 Aug; 12(4):409-17. PubMed ID: 26033878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple imputation for early stopping of a complex clinical trial.
    Betensky RA
    Biometrics; 1998 Mar; 54(1):229-42. PubMed ID: 9544518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stochastic curtailing and conditional power in matched case-control studies.
    Hunsberger S; Sorlie P; Geller NL
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):663-70. PubMed ID: 8023041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The perils with the misuse of predictive power.
    Dallow N; Fina P
    Pharm Stat; 2011; 10(4):311-7. PubMed ID: 20967762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint monitoring and prediction of accrual and event times in clinical trials.
    Zhang X; Long Q
    Biom J; 2012 Nov; 54(6):735-49. PubMed ID: 22907686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Markov process as a general method for nonparametric analysis of right-censored medical data.
    Hillis A; Maguire M; Hawkins BS; Newhouse MM
    J Chronic Dis; 1986; 39(8):595-604. PubMed ID: 3525597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.